S

Savara
D

SVRA

5.36500
USD
0.23
(4.38%)
مغلق
حجم التداول
70,160
الربح لكل سهم
-1
العائد الربحي
-
P/E
-11
حجم السوق
1,091,604,988
أصول ذات صلة الأخبار المقالات

العنوان: Savara

القطاع: Healthcare
الصناعة: Biotechnology
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.